Impact of hepatectomy and postoperative adjuvant transarterial chemoembolization on serum tumor markers and prognosis in intermediate-stage hepatocellular carcinoma

Figure 1 Changes in tumour markers of patients before and after treatment. A: Changes in alpha-fetoprotein levels before and after treatment in the observation and control groups; B: Changes in carcinoembryonic antigen levels before and after treatment in the observation and control groups; C: Changes in total bilirubin levels before and after treatment in the observation and control groups; D: Changes in alanine aminotransferase levels before and after treatment in the observation and control groups; E: Changes in aspartate aminotransferase levels before and after treatment in the observation and control groups. ^aP < 0.0001. AFP: Alpha-fetoprotein; CEA: Carcinoembryonic antigen; TBIL: Total bilirubin; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase.

Figure 2 Survival curves for prognostic factors. A: Effect of different treatment regimens on 3-year survival of patients; B: Effect of cirrhosis on 3-year survival in patients with cirrhosis; C: Effect of tumour number on 3-year survival of patients; D: Effect of maximum tumour diameter on the 3-year survival rate of patient patients; E: Effect of alpha-fetoprotein on 3-year survival rate of patients.